List of Excipients in API ERIBULIN MESYLATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ERIBULIN MESYLATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| BSP Pharmaceuticals SpA | HALAVEN | eribulin mesylate | 43624-002 | ALCOHOL | |
| BSP Pharmaceuticals SpA | HALAVEN | eribulin mesylate | 43624-002 | WATER | |
| Eisai Inc | HALAVEN | eribulin mesylate | 62856-389 | ALCOHOL | |
| Eisai Inc | HALAVEN | eribulin mesylate | 62856-389 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ERIBULIN MESYLATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 | ALCOHOL |
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 | HYDROCHLORIC ACID |
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 | SODIUM HYDROXIDE |
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 | WATER |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ERIBULIN MESYLATE
Excipient focus: ALCOHOL
ERIBULIN MESYLATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 |
| Sandoz Inc | eribulin mesylate | 0781-3391 |
| Baxter Healthcare Company | eribulin mesylate | 10019-080 |
| Kindos Pharmaceuticals Co Ltd | eribulin mesylate | 40033-364 |
| >Company | >Ingredient | >NDC |
ERIBULIN MESYLATE drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
ERIBULIN MESYLATE drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 |
| Sandoz Inc | eribulin mesylate | 0781-3391 |
| Baxter Healthcare Company | eribulin mesylate | 10019-080 |
| Kindos Pharmaceuticals Co Ltd | eribulin mesylate | 40033-364 |
| >Company | >Ingredient | >NDC |
ERIBULIN MESYLATE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| BSP Pharmaceuticals SpA | eribulin mesylate | 43624-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
ERIBULIN MESYLATE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co Ltd | eribulin mesylate | 71731-4171 |
| >Company | >Ingredient | >NDC |
ERIBULIN MESYLATE drug variants not containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 |
| Sandoz Inc | eribulin mesylate | 0781-3391 |
| Baxter Healthcare Company | eribulin mesylate | 10019-080 |
| Kindos Pharmaceuticals Co Ltd | eribulin mesylate | 40033-364 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
ERIBULIN MESYLATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 |
| Sandoz Inc | eribulin mesylate | 0781-3391 |
| Baxter Healthcare Company | eribulin mesylate | 10019-080 |
| Kindos Pharmaceuticals Co Ltd | eribulin mesylate | 40033-364 |
| >Company | >Ingredient | >NDC |
ERIBULIN MESYLATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BSP Pharmaceuticals SpA | eribulin mesylate | 43624-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
ERIBULIN MESYLATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | eribulin mesylate | 0143-9167 |
| Sandoz Inc | eribulin mesylate | 0781-3391 |
| Baxter Healthcare Company | eribulin mesylate | 10019-080 |
| Kindos Pharmaceuticals Co Ltd | eribulin mesylate | 40033-364 |
| >Company | >Ingredient | >NDC |
ERIBULIN MESYLATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
